BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36073574)

  • 1. TIMP1 promotes cell proliferation and invasion capability of right-sided colon cancers via the FAK/Akt signaling pathway.
    Ma B; Ueda H; Okamoto K; Bando M; Fujimoto S; Okada Y; Kawaguchi T; Wada H; Miyamoto H; Shimada M; Sato Y; Takayama T
    Cancer Sci; 2022 Dec; 113(12):4244-4257. PubMed ID: 36073574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway.
    Song G; Xu S; Zhang H; Wang Y; Xiao C; Jiang T; Wu L; Zhang T; Sun X; Zhong L; Zhou C; Wang Z; Peng Z; Chen J; Wang X
    J Exp Clin Cancer Res; 2016 Sep; 35(1):148. PubMed ID: 27644693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of single-cell transcriptomics and epigenetic analysis reveals enhancer-controlled TIMP1 as a regulator of ferroptosis in colorectal cancer.
    Li M; Ni QY; Yu SY
    Genes Genomics; 2024 Jan; 46(1):121-133. PubMed ID: 38032469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes.
    Lee MS; Menter DG; Kopetz S
    J Natl Compr Canc Netw; 2017 Mar; 15(3):411-419. PubMed ID: 28275039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer.
    Johnson SM; Gulhati P; Rampy BA; Han Y; Rychahou PG; Doan HQ; Weiss HL; Evers BM
    J Am Coll Surg; 2010 May; 210(5):767-76, 776-8. PubMed ID: 20421047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention for Colorectal Cancers: Are Chemopreventive Effects Different Between Left and Right Sided Colorectal Cancers?
    Arai J; Suzuki N; Niikura R; Ooki D; Kawahara T; Honda T; Hasatani K; Yoshida N; Nishida T; Sumiyoshi T; Kiyotoki S; Ikeya T; Arai M; Ishibashi R; Aoki T; Tsuji Y; Yamamichi N; Hayakawa Y; Fujishiro M
    Dig Dis Sci; 2022 Nov; 67(11):5227-5238. PubMed ID: 35230578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids.
    Gonzalez-Exposito R; Semiannikova M; Griffiths B; Khan K; Barber LJ; Woolston A; Spain G; von Loga K; Challoner B; Patel R; Ranes M; Swain A; Thomas J; Bryant A; Saffery C; Fotiadis N; Guettler S; Mansfield D; Melcher A; Powles T; Rao S; Watkins D; Chau I; Matthews N; Wallberg F; Starling N; Cunningham D; Gerlinger M
    J Immunother Cancer; 2019 Apr; 7(1):101. PubMed ID: 30982469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective cohort study of TIMP1 as prognostic biomarker in gastric and colon cancer.
    Macedo FC; Cunha N; Pereira TC; Soares RF; Monteiro AR; Bonito N; Valido F; Sousa G
    Chin Clin Oncol; 2022 Dec; 11(6):43. PubMed ID: 36509552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism rs2682818 participates in the progression of colorectal carcinoma via miR-618-TIMP1 regulatory axis.
    Shao W; Xia H; Lan Q; Gu J; Huang H; Zheng F; Zheng Y
    Sci Rep; 2021 Nov; 11(1):23186. PubMed ID: 34848810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left-Sided microsatellite unstable colorectal cancers show less frequent methylation of hMLH1 and CpG island methylator phenotype than right-sided ones.
    Tanaka J; Watanabe T; Kanazawa T; Tada T; Kazama Y; Tanaka T; Nagawa H
    J Surg Oncol; 2007 Dec; 96(7):611-8. PubMed ID: 17786961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine kinase 1 promotes the metastasis of colorectal cancer by inducing the epithelial‑mesenchymal transition mediated by the FAK/AKT/MMPs axis.
    Liu SQ; Xu CY; Wu WH; Fu ZH; He SW; Qin MB; Huang JA
    Int J Oncol; 2019 Jan; 54(1):41-52. PubMed ID: 30365116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA ABHD11-AS1 promotes colorectal cancer progression and invasion through targeting the integrin subunit alpha 5/focal adhesion kinase/phosphoinositide 3 kinase/Akt signaling pathway.
    Luo J; Jiang Y; Wu L; Zhuo D; Zhang S; Jiang X; Sun Y; Huang Y
    Aging (Albany NY); 2021 Aug; 13(16):20179-20191. PubMed ID: 34375304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs Associated With Biological Pathways of Left- and Right-sided Colorectal Cancer.
    Eneh S; Heikkinen S; Hartikainen JM; Kuopio T; Mecklin JP; Kosma VM; Mannermaa A
    Anticancer Res; 2020 Jul; 40(7):3713-3722. PubMed ID: 32620610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis.
    Li Y; Feng Y; Dai W; Li Q; Cai S; Peng J
    Clin Colorectal Cancer; 2019 Mar; 18(1):e104-e116. PubMed ID: 30448100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data.
    Liang L; Zeng JH; Qin XG; Chen JQ; Luo DZ; Chen G
    Cell Physiol Biochem; 2018; 48(2):475-490. PubMed ID: 30016783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation.
    Toricelli M; Melo FH; Peres GB; Silva DC; Jasiulionis MG
    Mol Cancer; 2013 Mar; 12():22. PubMed ID: 23522389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TFF1 antagonizes TIMP-1 mediated proliferative functions in gastric cancer.
    Omar OM; Soutto M; Bhat NS; Bhat AA; Lu H; Chen Z; El-Rifai W
    Mol Carcinog; 2018 Nov; 57(11):1577-1587. PubMed ID: 30035371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue inhibitor of metalloproteinase 1 suppresses growth and differentiation of osteoblasts and differentiation of osteoclasts by targeting the AKT pathway.
    Xi Y; Huang H; Zhao Z; Ma J; Chen Y
    Exp Cell Res; 2020 Apr; 389(2):111930. PubMed ID: 32113948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing homoharringtonine for thyroid cancer treatment through TIMP1/FAK/PI3K/AKT signaling pathway.
    Xi C; Zhang G; Sun N; Liu M; Ju N; Shen C; Song H; Luo Q; Qiu Z
    iScience; 2024 Jun; 27(6):109829. PubMed ID: 38770133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.